Concepts (59)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Phylogeography | 2 | 2021 | 824 | 0.81 | Why? |
| Phylogeny | 4 | 2021 | 13341 | 0.36 | Why? |
| Mutation | 5 | 2021 | 12376 | 0.34 | Why? |
| South Africa | 6 | 2021 | 3326 | 0.32 | Why? |
| Immune Evasion | 3 | 2021 | 2081 | 0.23 | Why? |
| Whole Genome Sequencing | 3 | 2021 | 3239 | 0.22 | Why? |
| Selection, Genetic | 2 | 2021 | 691 | 0.21 | Why? |
| Molecular Typing | 1 | 2021 | 280 | 0.20 | Why? |
| Genetic Fitness | 1 | 2021 | 339 | 0.19 | Why? |
| DNA Mutational Analysis | 1 | 2021 | 581 | 0.18 | Why? |
| Datasets as Topic | 1 | 2021 | 1404 | 0.13 | Why? |
| Genome, Viral | 4 | 2021 | 13157 | 0.11 | Why? |
| Sequence Analysis, RNA | 1 | 2021 | 2290 | 0.11 | Why? |
| Evolution, Molecular | 2 | 2021 | 3691 | 0.10 | Why? |
| Antibodies, Neutralizing | 3 | 2021 | 25288 | 0.10 | Why? |
| High-Throughput Nucleotide Sequencing | 1 | 2020 | 3633 | 0.09 | Why? |
| Models, Molecular | 1 | 2021 | 7616 | 0.08 | Why? |
| HIV-1 | 1 | 2021 | 3365 | 0.08 | Why? |
| Immunogenicity, Vaccine | 1 | 2021 | 4624 | 0.07 | Why? |
| Molecular Diagnostic Techniques | 1 | 2020 | 4239 | 0.07 | Why? |
| Real-Time Polymerase Chain Reaction | 1 | 2021 | 11367 | 0.06 | Why? |
| Time Factors | 2 | 2021 | 31397 | 0.05 | Why? |
| Vaccine Potency | 1 | 2021 | 339 | 0.05 | Why? |
| Antibodies, Viral | 2 | 2021 | 51949 | 0.04 | Why? |
| Polyproteins | 1 | 2021 | 814 | 0.04 | Why? |
| Neutralization Tests | 2 | 2021 | 6698 | 0.04 | Why? |
| DNA Primers | 1 | 2021 | 1170 | 0.04 | Why? |
| Spike Glycoprotein, Coronavirus | 3 | 2021 | 37182 | 0.04 | Why? |
| Treatment Failure | 1 | 2021 | 2106 | 0.03 | Why? |
| Adenoviridae | 1 | 2021 | 1151 | 0.03 | Why? |
| Recombination, Genetic | 1 | 2021 | 1265 | 0.03 | Why? |
| Multiplex Polymerase Chain Reaction | 1 | 2021 | 1439 | 0.03 | Why? |
| Humans | 10 | 2021 | 930598 | 0.03 | Why? |
| Viral Proteins | 2 | 2021 | 7370 | 0.03 | Why? |
| Netherlands | 1 | 2021 | 3533 | 0.03 | Why? |
| Double-Blind Method | 1 | 2021 | 5988 | 0.02 | Why? |
| Cross Reactions | 1 | 2021 | 4374 | 0.02 | Why? |
| Cell Line | 1 | 2021 | 12040 | 0.02 | Why? |
| Pandemics | 3 | 2021 | 389249 | 0.02 | Why? |
| Immunization, Passive | 1 | 2021 | 10067 | 0.02 | Why? |
| Receptors, Virus | 1 | 2021 | 5659 | 0.02 | Why? |
| Vero Cells | 1 | 2021 | 14117 | 0.02 | Why? |
| Reproducibility of Results | 1 | 2020 | 11304 | 0.02 | Why? |
| T-Lymphocytes | 1 | 2021 | 6670 | 0.02 | Why? |
| Travel | 1 | 2021 | 7220 | 0.01 | Why? |
| Adolescent | 2 | 2021 | 86841 | 0.01 | Why? |
| Young Adult | 2 | 2021 | 93724 | 0.01 | Why? |
| Sensitivity and Specificity | 1 | 2020 | 22971 | 0.01 | Why? |
| Betacoronavirus | 1 | 2020 | 204454 | 0.01 | Why? |
| Adult | 2 | 2021 | 244371 | 0.01 | Why? |
| Disease Outbreaks | 1 | 2021 | 27595 | 0.01 | Why? |
| Middle Aged | 2 | 2021 | 270681 | 0.01 | Why? |
| Pneumonia, Viral | 1 | 2020 | 243684 | 0.01 | Why? |
| Coronavirus Infections | 1 | 2020 | 253789 | 0.01 | Why? |
| Animals | 1 | 2021 | 78931 | 0.01 | Why? |
| Aged, 80 and over | 1 | 2021 | 88759 | 0.01 | Why? |
| Aged | 1 | 2021 | 215776 | 0.00 | Why? |
| Male | 1 | 2021 | 367725 | 0.00 | Why? |
| Female | 1 | 2021 | 380317 | 0.00 | Why? |
Tegally's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(59)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(276)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_